Wolverine Trading, LLC Nektar Therapeutics Transaction History

Wolverine Trading, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$4.16 - $13.72 $136,348 - $449,686	-32,776 Reduced 66.89%	16,221 $90,000
Q4 2021 Feb 14, 2022	SELL	$10.83 - $18.41 $32,186 - $54,714	-2,972 Reduced 5.72%	48,997 $686,000
Q3 2021 Nov 12, 2021	SELL	$13.07 - $18.84 $654,179 - $942,979	-50,052 Reduced 49.06%	51,969 $932,000
Q2 2021 Aug 06, 2021	BUY	$16.52 - $20.4 $214,760 - $265,200	13,000 Added 14.6%	102,021 $1.78 Million
Q1 2021 May 14, 2021	BUY	$16.56 - $25.46 $635,158 - $976,518	38,355 Added 75.7%	89,021 $1.74 Million

Q4 2020 Feb 12, 2021	SELL	$15.77 - $19.03 $26,698 - $32,217	-1,693 Reduced 3.23%	50,666 $909,000
Q3 2020 Nov 13, 2020	SELL	$16.59 - $24.79 $22,131 - $33,069	-1,334 Reduced 2.48%	52,359 $884,000
Q2 2020 Aug 13, 2020	SELL	$16.86 - $23.44 $236,056 - $328,183	-14,001 Reduced 20.68%	53,693 $1.2 Million
Q1 2020 May 11, 2020	BUY	$14.47 - $27.96 $10,186 - $19,683	704 Added 1.05%	67,694 $1.22 Million
Q4 2019 Feb 12, 2020	SELL	$15.87 - $23.12 $114,914 - $167,411	-7,241 Reduced 9.75%	66,990 $1.39 Million
Q3 2019 Nov 14, 2019	BUY	$16.91 - $36.27 $1.15 Million - $2.46 Million	67,962 Added 1084.1%	74,231 $1.33 Million
Q2 2019 Aug 20, 2019	SELL	$31.0 - $36.3 $61,783 - $72,345	-1,993 Reduced 24.12%	6,269 $223,000
Q4 2018 Feb 14, 2019	SELL	$30.43 - $56.65 $720,247 - $1.34 Million	-23,669 Reduced 74.13%	8,262 $278,000
Q4 2017 Feb 14, 2018	BUY	$23.02 - $60.5 $735,051 - $1.93 Million	31,931	31,931 $1.91 Million

128

111M

150K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $242M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.